Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pratik Bhagunde

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen designPratik Bhagunde, Renu Singh, Kimberly R Ledesma, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 4, 2019
A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactamPratik Bhagunde, Zufei Zhang, Fred Racine, et al.
Journal of Clinical Pharmacology|March 24, 2025
Efanesoctocog Alfa Population Pharmacokinetics and Repeated Time-To-Event Analysis of Bleeds in Adults, Adolescents, and Children with Severe Hemophilia ANancy Wong, Pratik Bhagunde, Joakim Nyberg, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Novel modeling framework to guide design of optimal dosing strategies for β-lactamase inhibitorsPratik Bhagunde, Kai-Tai Chang, Elizabeth B Hirsch, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Mathematical modeling to characterize the inoculum effectPratik Bhagunde, Kai-Tai Chang, Renu Singh, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 12, 2019
Population Pharmacokinetic Analysis for Imipenem-Relebactam in Healthy Volunteers and Patients With Bacterial InfectionsPratik Bhagunde, Parul Patel, Mallika Lala, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 16, 2026
Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic ModelPratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentLarisa Reyderman, Natasha Penner, Pratik Bhagunde, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2026
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatmentPratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Clinical Pharmacology in Drug Development|March 27, 2020
Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy ParticipantsKeith Boundy, Yang Liu, Pratik Bhagunde, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen designPratik Bhagunde, Renu Singh, Kimberly R Ledesma, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 4, 2019
A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactamPratik Bhagunde, Zufei Zhang, Fred Racine, et al.
Journal of Clinical Pharmacology|March 24, 2025
Efanesoctocog Alfa Population Pharmacokinetics and Repeated Time-To-Event Analysis of Bleeds in Adults, Adolescents, and Children with Severe Hemophilia ANancy Wong, Pratik Bhagunde, Joakim Nyberg, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Novel modeling framework to guide design of optimal dosing strategies for β-lactamase inhibitorsPratik Bhagunde, Kai-Tai Chang, Elizabeth B Hirsch, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Mathematical modeling to characterize the inoculum effectPratik Bhagunde, Kai-Tai Chang, Renu Singh, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 12, 2019
Population Pharmacokinetic Analysis for Imipenem-Relebactam in Healthy Volunteers and Patients With Bacterial InfectionsPratik Bhagunde, Parul Patel, Mallika Lala, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 16, 2026
Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic ModelPratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentLarisa Reyderman, Natasha Penner, Pratik Bhagunde, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 23, 2026
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatmentPratik Bhagunde, Natasha Penner, Brian A Willis, et al.
Clinical Pharmacology in Drug Development|March 27, 2020
Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy ParticipantsKeith Boundy, Yang Liu, Pratik Bhagunde, et al.
Pageof 2